NCT02180919.

Methods	Study design: unknown centres; open‐label, cross‐over randomised controlled trial Duration: 52 weeks Setting: unknown
Participants	Population: 85 adults recruited from United Kingdom Baseline characteristics: unknown Inclusion criteria: heart failure patients: ≥ 18 years of age in New York Heart Association Class II to IV at time of discharge; respiratory patients: > 18 years with diagnosis of COPD or respiratory insufficiency due to chronic respiratory disease diagnosed by a respiratory physician; arterial oxygen saturation ≤ 90%, LTOT Exclusion criteria: < 18 years of age, cognitive impairment to interfere with study
Interventions	Measurements taken at baseline and at 3, 6, 9, and 12 months Treatment arms CE marked Philips Motiva system linked to patients, TV then transmitting data to a secure server daily
Outcomes	Primary outcomes: time to first exacerbation Secondary outcomes: compliance with telemonitoring, self‐efficacy, contact with GP, emergency department visits, HADS, Minnesota Living With Heart Failure Questionnaire, EQ‐5D, CRQ
Notes	Funding: Royal Brompton & Harefield NHS Foundation Trust Other identifier:NCT02180919; 10/H0704/19